创业板医药生物行业上市公司绩效评价实证检验

Empirical Analysis on Performance Evaluation of the GEM's Listed Companies of Medicine&Biology Industry

创业板与主板、中小板相比,上市规则和运作规范均有所不同,导致利益相关者对创业板上市公司的绩效进行评价时所关注的信息也有所不同,为此有必要针对创业板市场科学地构建绩效评价体系。借助因子分析和层次分析方法,以医药生物行业为例,对创业板上市公司的绩效进行实证检验,以期为投资者提供参考。

Compared to the main board, small and medium enterprise board, GEM holds different listing rules and operation standard.So the information concerned by the stakeholders of the GEM＇s Listed Companies is also different when conducting performance evaluation.Therefore it is necessary to construct the scientific GEM performance evaluation system. By means of factor analysis and hierarchical analysis method, the paper conducts the empirical research on the GEM＇s Listed Companies of Medicine＆Biology Industry to provide reference for investors..